223 related articles for article (PubMed ID: 16332144)
21. Intravenous immunoglobulin for treatment of neuromuscular disease.
Ruzhansky K; Brannagan TH
Neurol Clin Pract; 2013 Oct; 3(5):440-445. PubMed ID: 29473612
[TBL] [Abstract][Full Text] [Related]
22. Treatment of chronic dysimmune polyneuropathies.
Léger JM
Transfus Sci; 1999 Feb; 20(1):63-7. PubMed ID: 10621562
[TBL] [Abstract][Full Text] [Related]
23. Management of chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA
Drugs; 2003; 63(3):275-87. PubMed ID: 12534332
[TBL] [Abstract][Full Text] [Related]
24. The spectrum of acquired demyelinating polyradiculoneuropathy.
Hughes RA
Acta Neurol Belg; 1994; 94(2):128-32. PubMed ID: 8036880
[TBL] [Abstract][Full Text] [Related]
25. Systematic reviews of treatment for inflammatory demyelinating neuropathy.
Hughes RA
J Anat; 2002 Apr; 200(4):331-9. PubMed ID: 12090400
[TBL] [Abstract][Full Text] [Related]
26. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
Lehmann HC; Hartung HP
J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913
[TBL] [Abstract][Full Text] [Related]
27. Subcutaneous immunoglobulin treatment in CIDP and MMN. Efficacy, treatment satisfaction and costs.
Markvardsen LH; Harbo T
J Neurol Sci; 2017 Jul; 378():19-25. PubMed ID: 28566163
[TBL] [Abstract][Full Text] [Related]
28. [Dysimmune neuropathies: current diagnosis and therapy].
Léger JM; Larue S; Dashi F
Rev Prat; 2008 Nov; 58(17):1887-9, 1892-4. PubMed ID: 19157204
[TBL] [Abstract][Full Text] [Related]
29. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
30. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines.
Dalakas MC
Muscle Nerve; 1999 Nov; 22(11):1479-97. PubMed ID: 10514226
[TBL] [Abstract][Full Text] [Related]
31. Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies.
Comi G; Nemni R; Amadio S; Galardi G; Leocani L
Mult Scler; 1997 Apr; 3(2):93-7. PubMed ID: 9291161
[TBL] [Abstract][Full Text] [Related]
32. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
Busby M; Donaghy M
J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
[TBL] [Abstract][Full Text] [Related]
33. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
Dalakas MC
JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
[TBL] [Abstract][Full Text] [Related]
34. Therapies in Autoimmune Peripheral Neuropathies beyond Intravenous Immunoglobulin, Plasma Exchange and Corticosteroids: An Analytical Review.
Sivadasan A; Bril V
Transfus Med Rev; 2022 Oct; 36(4):220-229. PubMed ID: 36253247
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune-mediated neuropathies.
Gallia F; Balducci C; Nobile-Orazio E
J Peripher Nerv Syst; 2016 Jun; 21(2):82-4. PubMed ID: 26817673
[TBL] [Abstract][Full Text] [Related]
36. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
Brannagan TH
Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
[TBL] [Abstract][Full Text] [Related]
37. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
38. Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP.
van Doorn PA; Kuitwaard K; Jacobs BC
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():38-40. PubMed ID: 21696496
[TBL] [Abstract][Full Text] [Related]
39. [Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy].
Hughes RA
Rev Neurol (Paris); 2002 Dec; 158(123):32-36. PubMed ID: 12690331
[TBL] [Abstract][Full Text] [Related]
40. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
Gorson KC; Natarajan N; Ropper AH; Weinstein R
Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
